human
coronavirus
one
main
caus
upper
respiratori
tract
infect
human
often
respons
mild
ill
associ
ill
requir
hospit
studi
assay
one
human
coronavirus
develop
use
truncat
recombin
nucleocapsid
n
protein
antigen
enzym
immunosorb
assay
elisa
evalu
use
serum
collect
patient
healthi
adult
patient
respiratori
viru
infect
result
show
diagnost
sensit
specif
assay
respect
evalu
clinic
util
elisa
serum
sampl
collect
patient
outbreak
infect
previous
identifi
posit
whole
n
elisa
screen
result
diagnosi
agreement
test
method
result
suggest
assay
offer
reliabl
method
detect
infect
may
use
tool
coronaviru
seroepidemiolog
studi
publish
elsevi
bv
see
front
matter
publish
elsevi
bv
human
coronavirus
hcov
first
identifi
hamr
et
al
worldwid
outbreak
sever
acut
respiratori
syndrom
sar
subsequ
isol
new
hcov
famili
member
van
der
hoek
et
al
woo
et
al
consider
attent
recent
focus
understand
molecular
divers
preval
clinic
impact
sequenc
analys
classifi
four
identifi
hcov
two
group
group
contain
contain
seropreval
estim
hcov
rang
respiratori
infect
woo
et
al
though
infect
primarili
associ
mild
respiratori
symptom
coronavirus
link
sever
infect
neuroinvas
diseas
even
fatal
vulnera
ble
subpopul
elderli
prompt
interest
epidemiolog
arbour
et
al
patrick
et
al
rota
et
al
howev
epidemiolog
survey
larg
scale
surveil
studi
limit
sensit
specif
current
diagnost
approach
lehmann
et
al
hcov
infect
induc
antibodi
cross
react
among
hcov
make
difficult
estim
preval
infect
differ
hcov
virus
without
neutral
assay
develop
specif
enzym
immunoassay
eia
hcov
strain
would
help
clarifi
strainspecif
pattern
infect
highli
specif
rapid
diagnost
assay
would
significantli
improv
surveil
investig
distribut
coronavirus
made
singl
positivestrand
rna
genom
encod
four
major
structur
protein
spike
nucleocapsid
n
membran
envelop
e
nucleocapsid
protein
recogn
import
target
develop
hcov
diagnost
reliabl
induc
good
antibodi
respons
mourez
et
al
howev
n
protein
sequenc
conserv
among
hcov
therefor
antibodi
detect
may
induc
hcov
result
fals
posit
result
hcov
strain
interest
chan
et
al
mourez
et
al
sever
et
al
analysi
aa
sequenc
hcov
n
protein
suggest
part
protein
could
provid
specif
antigen
eia
investig
possibl
serolog
assay
use
truncat
recombin
n
protein
develop
evalu
indirect
enzymelink
immunosorb
assay
elisa
serum
sampl
group
group
sarscov
group
infect
patient
antigen
assess
diagnost
accuraci
optim
cutoff
sensit
specif
one
truncat
n
protein
gave
minim
crossreact
allow
serolog
differenti
past
infect
cov
infect
estim
seropreval
healthi
adult
acut
convalesc
phase
sera
n
acut
n
convalesc
n
acut
n
convalesc
patient
kindli
provid
dr
ann
falsey
univers
rochest
school
medicin
sera
exhibit
least
fourfold
rise
antibodi
titer
test
whole
viru
eia
falsey
person
commun
serum
sampl
collect
patient
laboratoryconfirm
sarscov
infect
healthi
adult
donor
exposur
sarscov
addit
acut
n
convalesc
n
specimen
collect
patient
n
posit
n
neg
respiratori
outbreak
wisconsin
nurs
home
fall
infect
statu
determin
realtim
pcr
wisconsin
state
laboratori
hygien
cdc
andor
serolog
test
cdc
specimen
use
studi
exempt
cdc
institut
review
board
review
cfr
b
polyclon
mous
sera
collect
week
old
mice
subcutan
sc
immun
ugml
recombin
n
n
protein
emulsifi
titermax
gold
sigma
hind
limb
mice
boost
week
postimmun
use
dose
antigen
dulbecco
phosphat
buffer
salin
intraperiton
administr
two
week
final
boost
anim
euthan
blood
collect
antibodi
titer
determin
screen
serum
sampl
immun
antigen
studi
perform
accord
guidelin
institut
anim
care
use
committe
serum
sampl
kept
aliquot
c
use
protein
sequenc
n
protein
genbank
id
compar
nation
center
biotechn
inform
ncbi
pair
wise
blast
n
protein
sequenc
group
hcov
genbank
id
genbank
id
group
hcov
genbank
id
well
sarscov
genbank
id
sequenc
correspond
truncat
n
protein
also
align
whole
n
protein
sequenc
cov
rna
extract
lysat
infect
cell
gift
erdman
cdc
use
qiamp
tm
viral
rna
kit
qiagen
valencia
ca
truncat
n
gene
amplifi
revers
transcriptas
rt
polymeras
chain
reaction
pcr
primer
design
previous
report
nucleotid
sequenc
n
gene
genbank
id
nc
oligonucleotid
primer
truncat
forward
primer
revers
primer
forward
primer
revers
primer
ctcgaattcttattataatct
forward
primer
revers
primer
ctcgaattcttattatat
amplifi
gene
clone
vector
encod
ctermin
polyhistidin
tag
gift
dr
xin
zhang
emori
univers
sequenc
ident
express
construct
confirm
sequenc
construct
transform
escherichia
coli
strain
cell
invitrogen
carlsbad
ca
express
recombin
protein
induc
addit
isopropyllthiodgalactopyranosid
iptg
recombin
protein
purifi
metal
affin
chromatographi
qiagen
valencia
ca
separ
gwell
stack
resolv
criterion
gradient
gel
biorad
laboratori
hercul
ca
analyz
coomassi
blue
stain
control
antigen
purifi
protein
e
coli
contain
vector
without
n
gene
express
describ
whole
n
protein
express
purifi
describ
purifi
protein
analyz
sdspage
western
blot
expect
protein
size
kd
reactiv
confirm
data
shown
purifi
histag
recombin
nucleocapsid
protein
gwell
separ
sdspage
biorad
laboratori
hercul
ca
transfer
onto
pvdf
membran
amersham
bioscienc
pagerul
tm
plu
fermenta
glen
burni
maryland
use
molecular
weight
standard
transfer
membran
incub
h
room
temperatur
block
buffer
contain
mm
tri
mm
nacl
tbst
bovin
serum
albumin
bsa
membran
wash
twice
mm
tbst
incub
h
room
temperatur
dilut
tetrahi
antibodi
qiagen
valencia
ca
block
buffer
membran
wash
twice
mm
tri
incub
room
temperatur
hr
dilut
horseradish
perioxidas
hrp
conjug
goat
antimous
iga
igm
igg
antibodi
kpl
gaithersburg
md
block
buffer
membran
wash
react
enhanc
chemiluminesc
fluoresc
system
ge
healthcar
piscataway
nj
min
chemiluminisc
signal
acquir
typhoon
imag
ge
healthcar
piscataway
nj
analyz
use
imagequ
softwar
analysi
pool
convalesc
sera
faint
band
seen
fragment
determin
nonspecif
recombin
n
protein
indirect
elisa
develop
use
modifi
version
recombin
sarscov
n
protein
elisa
previous
describ
hayn
et
al
briefli
flat
bottom
immulon
elisa
plate
thermo
scientif
rochest
ny
coat
purifi
recombin
n
protein
ngwell
protein
ngwell
protein
ngwell
protein
ngwell
control
antigen
ngwell
depend
posit
antigen
steril
phosphat
buffer
salin
pb
incub
overnight
c
optim
concentr
antigen
determin
checkerboard
titrat
data
shown
plate
wash
three
time
pb
contain
pbst
incub
dilut
serum
pb
contain
skim
milk
pbstm
hr
c
incub
plate
wash
three
time
pbst
incub
dilut
hrpconjug
goat
antihuman
igg
hl
kpl
gaithersburg
md
pbstm
h
c
subsequ
wash
azinodi
abt
peroxidas
substrat
kpl
gaithersburg
md
ad
well
incub
c
min
reaction
stop
use
abt
peroxidas
stop
solut
read
absorb
nm
nm
refer
filter
od
valu
neg
control
well
subtract
od
valu
antigenco
well
averag
od
valu
antigenco
well
calcul
mean
od
valu
serum
sampl
consid
crossreact
elisa
result
confirm
evalu
subset
sampl
western
blot
receiveroper
characterist
roc
analysi
area
curv
auc
optim
test
cutoff
determin
use
microsoft
excel
describ
previous
greiner
greiner
et
al
briefli
diagnost
sensit
se
specif
sp
estim
compar
elisa
test
result
gold
standard
result
specifi
viru
posit
neg
sampl
diagnost
accuraci
demonstr
roc
analysi
elisa
test
plot
se
summar
auc
valu
optim
test
cutoff
valu
ascertain
plot
percent
sensit
specif
od
valu
determin
intersect
two
curv
truncat
n
protein
amplifi
clone
express
vector
ctermin
tag
describ
section
purif
protein
analyz
sdspage
fig
western
blot
reactiv
antihi
antibodi
fig
expect
band
observ
approxim
kda
n
data
shown
kda
kda
kda
result
protein
use
antigen
subsequ
immunoassay
full
length
n
protein
show
homolog
cov
n
protein
show
highest
sequenc
homolog
anoth
group
hcov
truncat
n
protein
show
less
sequenc
homolog
cov
show
least
sequenc
homolog
overal
sequenc
homolog
amino
acid
ident
truncat
protein
cov
shown
tabl
evalu
antibodi
respons
truncat
n
protein
antigen
specif
igg
titer
twentysix
acut
n
convalesc
sera
n
patient
screen
reactiv
shown
fig
three
n
protein
detect
antibodi
convalescentphas
serum
specimen
averag
od
greater
howev
detect
acutephas
sera
limit
fig
predomin
antibodi
respons
protein
follow
respons
addit
serum
human
coronaviru
genbank
id
fulllength
nucleocapsid
protein
n
truncat
protein
aa
b
sequenc
whole
nucleocapsid
protein
coronaviru
compar
sequenc
whole
truncat
n
protein
nucleocapsid
protein
access
number
sarscov
genbank
id
human
coronaviru
genbank
id
human
coronaviru
genbank
id
human
coronaviru
genbank
id
c
valu
repres
percent
amino
acid
ident
determin
use
nation
center
biotechn
inform
ncbi
blast
sampl
convalesc
sarscov
n
acut
convalesc
n
patient
also
screen
elisa
determin
reactiv
antigen
fig
two
serum
sampl
one
acut
one
convalesc
differ
patient
show
reactiv
antigen
convalesc
sera
six
sar
patient
show
reactiv
protein
fragment
contrast
fragment
serum
sampl
patient
sarscov
serum
sam
ple
show
reactiv
whole
n
protein
fig
level
absorb
convalescentphas
sera
sarscov
infect
person
antigen
lower
whole
n
antigen
suggest
less
crossreact
sera
truncat
elisa
fig
due
limit
avail
serum
sampl
confirm
group
group
infect
patient
evalu
howev
hyperimmun
sera
mice
immun
n
protein
n
protein
test
show
reactiv
protein
minim
reactiv
whole
n
protein
data
shown
base
strong
reactiv
sera
protein
minim
crossreact
cov
sera
antigen
chosen
evalu
panel
known
posit
neg
sampl
screen
receiv
oper
characterist
roc
analysi
util
determin
assay
cutoff
roc
analysi
allow
data
normal
distribut
evalu
sensit
specif
determin
separ
null
hypothesi
roc
analysi
test
method
better
flip
coin
would
demonstr
diagon
line
roc
curv
area
curv
auc
equal
perfect
test
would
auc
given
limit
detect
acut
sera
protein
fig
roc
analysi
complet
base
result
screen
posit
convalesc
neg
serum
specimen
fig
auc
valu
data
shown
optim
cutoff
valu
posit
test
result
determin
plot
percent
sensit
specif
od
cutoff
valu
fig
cutoff
valu
set
od
valu
intersect
point
fig
correspond
sensit
specif
cutoff
valu
convalesc
sampl
posit
test
result
remain
sampl
produc
borderlin
result
sensit
protein
elisa
compar
whole
n
protein
elisa
fig
overal
mean
od
valu
acut
convalesc
specimen
higher
use
whole
n
protein
elisa
hcov
elisa
better
abil
detect
rise
antibodi
titer
acut
convalesc
specimen
whole
n
protein
elisa
use
establish
cutoff
valu
n
sar
n
serum
sampl
rescreen
elisa
one
acut
one
convalesc
serum
sampl
two
patient
convalesc
sera
six
sar
patient
show
reactiv
protein
specif
fig
overal
assay
perform
summar
tabl
panel
sera
collect
healthi
adult
donor
evalu
determin
seropreval
fig
sera
adult
donor
posit
presenc
antibodi
result
fell
within
confid
interv
cutoff
od
valu
consid
borderlin
result
n
borderlin
posit
sampl
confirm
posit
western
blot
analysi
data
shown
result
seropreval
infect
evalu
surveil
perform
assay
nineteen
acut
convalesc
serum
specimen
collect
patient
outbreak
infect
longterm
care
facil
locat
wisconsin
screen
infect
statu
patient
previous
determin
rtpcr
andor
serolog
diagnost
analysi
assay
detect
acut
convalesc
specimen
posit
fig
two
addit
convalesc
serum
specimen
two
patient
neg
data
shown
consist
previou
diagnost
test
patient
consid
seroposit
two
remain
patient
seroneg
determin
elisa
cov
nucleocapsid
protein
use
antigen
serolog
diagnosi
infect
conserv
sequenc
homolog
among
variou
cov
n
protein
led
need
specif
antigen
detect
antibodi
specif
hcov
includ
cov
n
protein
highli
conserv
region
fyylgtgp
occur
ntermin
portion
rota
et
al
immunogen
would
induc
crossreact
antibodi
coronavirus
chan
et
al
sun
meng
woo
et
al
patrick
et
al
one
approach
reduc
antigen
crossreact
divid
n
protein
three
region
evalu
result
truncat
protein
serum
specimen
sar
covinfect
person
antibodi
assay
expect
sarscov
posit
sera
show
reactiv
protein
reactiv
protein
posit
sera
show
compar
reactiv
fragment
serum
sampl
posit
cov
infect
ie
sar
show
low
moder
reactiv
convalescentphas
sera
show
high
reactiv
protein
acut
phase
sera
show
minim
reactiv
truncat
n
protein
consist
origin
individu
suscept
infect
lack
reactiv
acutephas
specimen
also
demonstr
assay
base
protein
specif
base
full
length
n
fig
three
truncat
protein
fragment
lowest
sequenc
homolog
coronaviru
nucleocapsid
protein
associ
highest
signal
convalesc
sera
chosen
antigen
addit
evalu
roc
analysi
provid
mean
determin
assay
cutoff
valu
popul
prior
infect
statu
expect
antibodi
posit
unknown
cutoff
valu
base
elisa
exhibit
high
diagnost
accuraci
although
sampl
size
specimen
limit
power
cutoff
calcul
base
assay
demonstr
strong
abil
confirm
posit
result
convalesc
specimen
confirm
remain
specimen
borderlin
posit
result
expans
hcov
serum
panel
includ
group
sampl
increas
overal
sampl
number
could
improv
diagnost
accuraci
refin
cutoff
valu
posit
borderlin
test
result
use
truncat
elisa
seropreval
healthi
adult
infect
demonstr
consist
earli
epidemiolog
survey
show
respons
upper
respiratori
tract
infect
mcintosh
et
al
wege
et
al
larson
et
al
consist
earli
seroepidemiolog
studi
seropreval
rate
lower
recent
report
rate
use
recombin
whole
nucleocapsidbas
igg
elisa
ifa
western
blot
assay
mourez
et
al
sever
et
al
studi
use
whole
n
protein
may
given
high
rate
past
infect
detect
antibodi
induc
hcov
crossreact
n
protein
studi
elisa
detect
antibodi
two
serum
sampl
patient
sera
six
sar
patient
antibodi
could
repres
prior
infect
antibodi
induc
virus
cross
react
due
limit
avail
human
sera
collect
confirm
infect
polyclon
sera
mice
immun
n
protein
screen
show
reactiv
protein
demonstr
specif
assay
respiratori
outbreak
associ
report
highlight
potenti
virul
infect
vulner
popul
elderli
care
facil
hospit
individu
underli
chronic
condit
patrick
et
al
birch
et
al
falsey
et
al
elsahli
et
al
glezen
et
al
studi
suggest
assay
provid
serolog
tool
assist
investig
hcov
outbreak
surveil
studi
